Cardiology Devices - Eastern Africa

The projected revenue in the Cardiology Devices market market in Eastern Africa is expected to reach US$198.60m by 2024.
This market is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 8.88%, leading to a market volume of US$303.80m by 2029.
It is worth noting that in a global comparison, the United States is expected to generate the highest revenue in this market, with an estimated amount of US$25.77bn in 2024.
The demand for advanced cardiology devices in Eastern Africa is growing rapidly due to an increasing prevalence of cardiovascular diseases.

Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Cardiology diagnostic & monitoring devices
Cardiology surgical devices
Implants such as pacemakers

Cardiology drugs
Cardiology supplements

The Cardiology Devices market in Eastern Africa is experiencing significant growth and development due to various factors.

Customer preferences: In recent years, there has been a growing demand for advanced cardiology devices in Eastern Africa. This can be attributed to the increasing awareness about cardiovascular diseases and the importance of early diagnosis and treatment. Patients and healthcare professionals are now seeking more accurate and efficient cardiology devices that can provide quick and reliable results. Additionally, there is a preference for non-invasive and minimally invasive procedures, leading to a higher demand for devices such as cardiac monitors, ECG machines, and ultrasound systems.

Trends in the market: One of the key trends in the Cardiology Devices market in Eastern Africa is the adoption of telemedicine and remote monitoring solutions. This trend has gained momentum due to the COVID-19 pandemic, as it allows patients to receive cardiology care without visiting hospitals or clinics. Telemedicine enables healthcare professionals to remotely monitor patients' heart health and provide timely interventions when necessary. This trend is expected to continue as it offers convenience, cost-effectiveness, and improved access to cardiology services, especially in rural and underserved areas. Another trend in the market is the increasing focus on preventive cardiology. Governments and healthcare organizations in Eastern Africa are implementing programs and initiatives to raise awareness about cardiovascular diseases and promote healthy lifestyles. This includes campaigns on the importance of regular exercise, a balanced diet, and smoking cessation. As a result, there is a growing demand for cardiology devices that can help individuals monitor their heart health and make informed decisions about their lifestyle choices.

Local special circumstances: Eastern Africa faces unique challenges in the healthcare sector, including limited healthcare infrastructure and a shortage of skilled healthcare professionals. These circumstances have led to a greater reliance on cardiology devices that are user-friendly, require minimal training, and can be easily operated in resource-constrained settings. Manufacturers are adapting their products to meet these local requirements, such as developing portable and battery-operated devices that can be used in remote areas with limited access to electricity.

Underlying macroeconomic factors: The economic growth and increasing disposable income in Eastern Africa are contributing to the development of the Cardiology Devices market. As the middle class expands, there is a greater ability to afford advanced medical technologies and treatments. Additionally, governments in the region are investing in healthcare infrastructure and expanding access to healthcare services, which further drives the demand for cardiology devices. In conclusion, the Cardiology Devices market in Eastern Africa is experiencing growth and development due to customer preferences for advanced and non-invasive devices, the adoption of telemedicine and remote monitoring solutions, the focus on preventive cardiology, local special circumstances, and underlying macroeconomic factors. This presents opportunities for manufacturers and healthcare providers to cater to the evolving needs of the market and improve cardiovascular care in the region.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.